Table 3:
Standard Deviation, SD, cells/μl | HR* per SD increase (95% CI) |
|||
---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||
| ||||
Neutrophils | 1252 | 1.33 (1.02–1.74) | 1.27 0.96–1.58) | 1.29 (1.00–1.80) |
Monocytes | 157 | 1.36 (1.07–1.74) | 1.36 (1.03–1.81) | 1.35 (1.02–1.79) |
Lymphocytes | 600 | 0.83 (0.59–1.17) | 0.76 (0.52–1.09) | 0.74 (0.51–1.09) |
Eosinophils | 126 | 1.20 (1.00–1.54) | 1.31 (1.02–1.69) | 1.31 (1.01–1.69) |
Basophils | 39 | 0.81 (0.57–1.15) | 0.76 (0.53–1.09) | 0.73 (0.51–1.05) |
HR (hazard ratio) per SD (standard deviation) increase in exposure.
Out of 4533 participants who were never smokers, 44 participants developed AAA over the follow-up. Incidence rate among never smokers at baseline was 46.6 per 100,000 person years.
Model 1: adjusted for age, sex and race-center
Model 2: adjusted for Model 1 covariates plus other differentials
Model 3: adjusted for Model 2 covariates plus height, total cholesterol, HDL cholesterol, triglycerides, use of cholesterol lowering medication, hypertension, diabetes, peripheral artery disease, and prevalent coronary heart disease at Visit 1